Ultralife Corporation reported a net loss of $0.5 million in Q1 2026, impacted by production disruptions from power outages, inventory integration, and bad weather. Sales declined 6.5% to $47.4 million, with weaker communications systems sales and lower battery product margins. Despite these setbacks, Ultralife's backlog reached a record $115.1 million, signaling strong future demand. The company plans to improve manufacturing efficiency and drive sales to restore profitability and generate cash flow in 2026.
The Vanguard Financials ETF (VFH) has received a reiterated buy rating due to its attractive valuation and strong technical momentum as the Q2 earnings season approaches. Trading just above 14 times earnings with a long-term EPS growth near 12%, it o...
The Hoya Capital High Dividend Yield ETF (RIET) provides investors with exposure to high-quality REITs and a high 10.4% dividend yield. However, the fund pays out more than it earns, causing its net asset value (NAV) to decline over time. Its perform...
LAB token soared 173.94% to $16.15, becoming the top gainer in the latest trading session with a market cap of $5.05 billion. This surge reflects growing investor interest in LAB's innovative blockchain solutions. Other notable gainers include Binanc...
Aptos Labs fixed a critical stale-cache bug in its Move virtual machine that could have allowed attackers to manipulate core blockchain data, risking up to $70 billion in assets. Security researchers demonstrated a proof-of-concept exploit with a 90%...
Aptos has fixed a critical vulnerability in its Move virtual machine that could have been exploited for only a few hundred dollars, posing a serious security risk. The flaw was discovered by ethical hackers and patched before any funds were lost or t...
